Novabridge Biosciences ADR (NBP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 68,263 | 291,506 | 480,016 | 552,935 | 729,315 |
| Marketable Securities | 105,135 | 20,221 | 34,134 | 118,188 | 4,832 |
| Receivables | N/A | N/A | N/A | 5,191 | 20,000 |
| Inventories | N/A | N/A | N/A | 4,274 | N/A |
| Other current assets | 3,295 | 18,185 | 11,639 | 69,768 | 64,806 |
| TOTAL | $176,693 | $329,912 | $525,789 | $750,356 | $818,953 |
| Non-Current Assets | |||||
| PPE Net | 201 | 1,777 | 8,821 | 7,174 | 3,873 |
| Investments And Advances | 30,824 | 0 | 4,473 | 55,253 | 101,890 |
| Intangibles | 0 | 0 | 40,808 | 44,289 | 43,375 |
| Other Non-Current Assets | 4,962 | 37,233 | 10,734 | 21,877 | 2,606 |
| TOTAL | $35,987 | $39,010 | $64,836 | $128,593 | $151,744 |
| Total Assets | $212,680 | $368,922 | $590,625 | $878,949 | $970,697 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | N/A | 2,748 | N/A | N/A |
| Accounts payable and accrued liabilities | 7,638 | 7,849 | 102,443 | 93,107 | 85,909 |
| Other current liabilities | N/A | N/A | 1,258 | N/A | N/A |
| TOTAL | $8,454 | $58,144 | $109,923 | $97,920 | $88,295 |
| Non-Current Liabilities | |||||
| Deferred Revenues | N/A | N/A | N/A | N/A | 1,151 |
| Other Non-Current Liabilities | 3,066 | 68,194 | 58,806 | 65,534 | 20,003 |
| TOTAL | $3,066 | $68,194 | $58,806 | $65,534 | $20,003 |
| Total Liabilities | $11,520 | $126,338 | $168,729 | $163,454 | $108,298 |
| Shareholders' Equity | |||||
| Common Shares | 19 | 19 | 19 | 20 | 17 |
| Retained earnings | -1,286,039 | -1,263,809 | -994,918 | -683,368 | -310,083 |
| Other shareholders' equity | 33,159 | 39,764 | 30,916 | -29,267 | -7,784 |
| TOTAL | $201,160 | $242,584 | $421,896 | $715,495 | $862,399 |
| Total Liabilities And Equity | $212,680 | $368,922 | $590,625 | $878,949 | $970,697 |